Enzyre is a UMC St. Radboud spin-off company which officially started in March 2017. It was founded with the mission to develop innovative diagnostic solutions to enable personalized medicine. The company holds the vision to create a point of care (POC) diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.
Looking for a particular Enzyre B.V. employee's phone or email?
The Enzyre B.V. annual revenue was $6 million in 2026.
Wim van Den Broek is the CEO and CFO of Enzyre B.V..
9 people are employed at Enzyre B.V..
Enzyre B.V. is based in Nijmegen, Gelderland.
The NAICS codes for Enzyre B.V. are [33, 325, 325413, 32, 339, 32541, 3254].
The SIC codes for Enzyre B.V. are [283, 382, 28, 38].